|
|||||
|
|
Glycogen synthase kinase‐3 inhibitors suppress the AR‐V7‐mediated transcription and selectively inhibit cell growth in AR‐V7‐positive prostate cancer cells |
|
| Authors: | Daisuke Nakata Ryokichi Koyama Kazuhide Nakayama Satoshi Kitazawa Tatsuya Watanabe Takahito Hara |
| Affiliation: | 1. Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan;2. Biomolecular Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan |
| Abstract: | |
| Keywords: | β ‐catenin AR‐V7 castration‐resistant prostate cancer glycogen synthase kinase‐3 |